Skip to main content

Infections News (Page 4)

Tattoo Inks Can Be Contaminated With Bacteria: Study

TUESDAY, July 2, 2024 — Getting inked could make you sick. In a first-of-its-kind study, researchers detected bacteria in commercial tattoo and permanent makeup inks, demonstrating that they could c...

Plane Hygiene: Staying Healthy at 35,000 Feet

SATURDAY, June 22, 2024 – The pandemic highlighted the risk that air travel carries for the spread of infectious diseases, and that risk remains even though the health emergency has passed....

Robust Gut Microbiome Can Help You Fight Infections

FRIDAY, June 21, 2024 – The bacteria colonizing your bowels play a key part in your risk for infection, new research shows. A study of more than 600 people hospitalized with infections found their...

Inappropriate Antibiotic Prescribing Identified in Safety-Net Populations

THURSDAY, May 30, 2024 – Inappropriate antibiotic prescribing is common with or without a plausible antibiotic indication, and inappropriate prescribing is also common in U.S. emergency department...

Had a Joint Replaced? Your Infection Risk May Rise After Chemotherapy

MONDAY, May 27, 2024 – If you're one of the millions of Americans walking around with a new knee or hip, your odds for an infection in that joint rise if you ever have to undergo cancer...

Americans Got Drug-Resistant Infections After Stem Cell Treatments in Mexico

THURSDAY, May 9, 2024 – Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved stem cell...

Avoid Some 'Project Watson' Dog Eye Wipes Due to Infection Danger

MONDAY, May 6, 2024 – Pets and pet owners who come into contact with Bausch & Lomb's "Project Watson" dog eye wipes could be at risk for infection if the products come from certain lots. The wipes...

Following Drop After COVID-19 Onset, Inappropriate Antibiotic Prescribing Is Up

WEDNESDAY, May 1, 2024 – There was an initial decrease in inappropriate antibiotic prescriptions following onset of COVID-19, followed by an increase, according to a study published online April 22...

FDA Approves DefenCath (taurolidine and heparin) to Reduce the Incidence of Catheter-Related Bloodstream Infections in Adult Hemodialysis Patients

Berkeley Heights, NJ – November 15, 2023 – CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of ...

FDA Approves Fetroja (cefiderocol) for the Treatment of Complicated Urinary Tract Infections

November 14, 2019 – The U.S. Food and Drug Administration today approved Fetroja (cefiderocol), an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary...

FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections

KENILWORTH, N.J.--(BUSINESS WIRE)-- July 17, 2019 Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved...

FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza

October 24, 2018 – Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older...

FDA Approves Nuzyra (omadacycline) for Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections

BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) – Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the U.S. Food and Drug Administration (FDA) has approved Nuzyra (omadacycline) for the...

FDA Approves Arikayce (amikacin liposome inhalation suspension) to treat Mycobacterium Avium Complex (MAC) Lung Disease

September 28, 2018 – The U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of...

Tetraphase Pharmaceuticals Announces FDA Approval of Xerava (eravacycline) for Complicated Intra-Abdominal Infections (cIAI)

WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) – Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Bacterial Infection, Urinary Tract Infection, Sexually Transmitted Diseases, Viral Infection